Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan J Lyons

Showing results (51-60 of 99) with videos related to

Pageof 10
Sort By:
International Archives of Allergy and Immunology|July 1, 2019
Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation SyndromePeter Valent, Patrizia Bonadonna, Karin Hartmann, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 17, 2021
Assessment of Osteoporosis and Fracture Risk in Mastocytosis within a North American CohortAyelet Makovoz, Jing Wang, Gloria Oshegbo, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 22, 2017
A common haplotype containing functional CACNA1H variants is frequently coinherited with increased TPSAB1 copy numberJonathan J Lyons, Stephanie C Stotz, Jack Chovanec, et al.
The Journal of Allergy and Clinical Immunology|March 23, 2021
Routine KIT p.D816V screening identifies clonal mast cell disease in patients with Hymenoptera allergy regularly missed using baseline tryptase levels aloneJulij Šelb, Matija Rijavec, Renato Eržen, et al.
Frontiers in Allergy|February 6, 2026
MRGPRX2-expressing mast cells are increased in the GI tract of individuals with active inflammatory bowel disease and hereditary α-tryptasemiaMichelle Galeas-Pena, Jonathan J Lyons, Dhana Llivichuzhca-Loja, et al.
The Journal of Allergy and Clinical Immunology|March 8, 2016
Diminution of signal transducer and activator of transcription 3 signaling inhibits vascular permeability and anaphylaxisValerie Hox, Michael P O'Connell, Jonathan J Lyons, et al.
Medrxiv : the Preprint Server for Health Sciences|January 8, 2026
MRGPRX2-expressing mast cells are increased in the GI tract of individuals with active inflammatory bowel disease and hereditary α-tryptasemiaMichelle Galeas-Pena, Jonathan J Lyons, Dhana Llivichuzhca-Loja, et al.
Bone|June 1, 2024
Underlying systemic mastocytosis in patients with unexplained osteoporosis: score proposalIlaria Tanasi, Lara Crosera, Francesco Taus, et al.
The Journal of Experimental Medicine|July 16, 2017
PD-L1 up-regulation restrains Th17 cell differentiation in <i>STAT3</i> loss- and <i>STAT1</i> gain-of-function patientsYuan Zhang, Chi A Ma, Monica G Lawrence, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|October 24, 2020
Novel PGM3 compound heterozygous variants with IgE-related dermatitis, lymphopenia, without syndromic featuresAna García-García, Monserrat Buendia Arellano, Àngela Deyà-Martínez, et al.
Pageof 10

Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
International Archives of Allergy and Immunology|July 1, 2019
Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation SyndromePeter Valent, Patrizia Bonadonna, Karin Hartmann, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 17, 2021
Assessment of Osteoporosis and Fracture Risk in Mastocytosis within a North American CohortAyelet Makovoz, Jing Wang, Gloria Oshegbo, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 22, 2017
A common haplotype containing functional CACNA1H variants is frequently coinherited with increased TPSAB1 copy numberJonathan J Lyons, Stephanie C Stotz, Jack Chovanec, et al.
The Journal of Allergy and Clinical Immunology|March 23, 2021
Routine KIT p.D816V screening identifies clonal mast cell disease in patients with Hymenoptera allergy regularly missed using baseline tryptase levels aloneJulij Šelb, Matija Rijavec, Renato Eržen, et al.
Frontiers in Allergy|February 6, 2026
MRGPRX2-expressing mast cells are increased in the GI tract of individuals with active inflammatory bowel disease and hereditary α-tryptasemiaMichelle Galeas-Pena, Jonathan J Lyons, Dhana Llivichuzhca-Loja, et al.
The Journal of Allergy and Clinical Immunology|March 8, 2016
Diminution of signal transducer and activator of transcription 3 signaling inhibits vascular permeability and anaphylaxisValerie Hox, Michael P O'Connell, Jonathan J Lyons, et al.
Medrxiv : the Preprint Server for Health Sciences|January 8, 2026
MRGPRX2-expressing mast cells are increased in the GI tract of individuals with active inflammatory bowel disease and hereditary α-tryptasemiaMichelle Galeas-Pena, Jonathan J Lyons, Dhana Llivichuzhca-Loja, et al.
Bone|June 1, 2024
Underlying systemic mastocytosis in patients with unexplained osteoporosis: score proposalIlaria Tanasi, Lara Crosera, Francesco Taus, et al.
The Journal of Experimental Medicine|July 16, 2017
PD-L1 up-regulation restrains Th17 cell differentiation in <i>STAT3</i> loss- and <i>STAT1</i> gain-of-function patientsYuan Zhang, Chi A Ma, Monica G Lawrence, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|October 24, 2020
Novel PGM3 compound heterozygous variants with IgE-related dermatitis, lymphopenia, without syndromic featuresAna García-García, Monserrat Buendia Arellano, Àngela Deyà-Martínez, et al.
Pageof 10